Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance Centers

Antoine Pariente (), Francesco Salvo, Virginie Bres and Jean-Luc Faillie
Additional contact information
Antoine Pariente: Univ Bordeaux, INSERM, BPH, U1219, Team AHeaD
Francesco Salvo: Univ Bordeaux, INSERM, BPH, U1219, Team AHeaD
Virginie Bres: CHU Montpellier, Service de Pharmacologie Médicale et Toxicologie-Centre Régional de Pharmacovigilance
Jean-Luc Faillie: CHU Montpellier, Service de Pharmacologie Médicale et Toxicologie-Centre Régional de Pharmacovigilance

Drug Safety, 2024, vol. 47, issue 9, No 9, 923 pages

Date: 2024
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-024-01437-1 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:47:y:2024:i:9:d:10.1007_s40264-024-01437-1

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-024-01437-1

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().